<DOC>
	<DOCNO>NCT02057458</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) many health consequence . A reduction ability perform exercise patient CF relate great death rate , steep decline lung function , frequent lung infection . However , physiological mechanism reduce exercise capacity unknown . The investigator laboratory recently publish first evidence systemic vascular dysfunction patient CF . Therefore , reasonable suspect blood vessel involve exercise intolerance CF . This study look 1 ) blood flow 2 ) artery function contribute exercise capacity CF .</brief_summary>
	<brief_title>Blood Flow Vascular Function Cystic Fibrosis</brief_title>
	<detailed_description>The disturb aspect Cystic Fibrosis ( CF ) associate premature death . Low exercise capacity predict death patient CF also associate steep decline lung function lung infection . A critical barrier improve exercise tolerance patient CF investigator lack knowledge regard different physiological mechanism contribute low exercise capacity . We compel data indicate blood vessel may contribute low exercise capacity CF . The impact proof concept investigation test Phosphodiesterase Type 5 inhibitor ( PDE5 ) inhibitors potential therapy CF explore blood flow endothelial function potential mechanism contribute exercise intolerance CF . Improvements exercise capacity contribute well quality live patient CF , also increase longevity patient .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Inclusion Criteria . Diagnosis CF healthy control Men woman ( great 18 yr . old ) Resting oxygen saturation ( room air ) great 90 % Forced expiratory volume ( FEV1 ) percent predict great 30 % Patients without CF relate diabetes Traditional CFtreatment medication Ability perform reliable/reproducible pulmonary function test ( PFT ) Clinically stable 2 week ( exacerbation need antibiotic treatment within 2 week test major change medical status ) Exclusion Criteria . Children le 17 year old Body mass le 20 kg A diagnosis pulmonary arterial hypertension ( PAH ) FEV1 le 30 % predict Resting oxygen saturation ( SpO2 ) less 90 % Selfreported smoker Current use vasoactive medication History migraine headache Pregnant nursing time investigation A clinical diagnosis cardiovascular disease , hypertension , CF relate diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>arterial stiffness</keyword>
	<keyword>flow-mediated dilation</keyword>
	<keyword>endothelial function</keyword>
	<keyword>pulse wave velocity</keyword>
	<keyword>inflammation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>pulmonary function test</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Lung Disease</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Exercise Capacity</keyword>
	<keyword>CF</keyword>
	<keyword>Muscle Function</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>Viagra</keyword>
	<keyword>Revatio</keyword>
</DOC>